𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The biology of Kaposi’s sarcoma-associated herpesvirus and the infection of human immunodeficiency virus

✍ Scribed by Di Qin; Chun Lu


Publisher
SP Wuhan Institute of Virology, CAS
Year
2008
Tongue
English
Weight
241 KB
Volume
23
Category
Article
ISSN
1674-0769

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Kaposi's sarcoma-associated herpesvirus
✍ Amy Chadburn; Ethel Cesarman; Roland G. Nador; Yi Fang Liu; Daniel M. Knowles 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

## Background: Kaposi's sarcoma-associated herpesvirus (kshv) dna sequences have been identified in approximately 95% of kaposi's sarcoma (ks) lesions and primary effusion lymphomas (pels), suggesting a pathogenetic role for this virus in these lesions. however, kshv has also been identified in a v

Genotypic and clinicopathological charac
✍ Takayuki Kanno; Yuko Sato; Tomoyuki Nakamura; Kouta Sakamoto; Tetsutaro Sata; Ha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

## Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV) is related causally to Kaposi's sarcoma, primary effusion lymphoma, and a subset of cases of multicentric Castleman's disease. As the numbers of acquired immunodeficiency syndrome (AIDS) patients have increased, KSHV‐associated diseases hav

Molecular epidemiology of Kaposi's sarco
✍ Elena Kadyrova; Vincent Lacoste; Renan Duprez; Kazimir Pozharissky; Vladimir Mol 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

## Abstract We report the molecular characterization of 38 new Kaposi's sarcoma‐associated herpesvirus (KSHV) strains from Russian patients with either classic (25 cases), epidemic/AIDS‐associated (7 cases), or posttransplant/immunosuppressed patients (6 cases), or Kaposi's sarcoma (KS). While a co

Treatment with taxanes of refractory or
✍ Laurence Fardet; Pierre-Emmanuel Stoebner; Herve Bachelez; Vincent Descamps; Del 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Abstract ## BACKGROUND Kaposi sarcoma (KS) is an angioproliferative disease that may represent a difficult therapeutic challenge in disseminated stages. The efficacy of taxanes (paclitaxel and docetaxel), as agents with antiangiogenic properties, has been described previously in the treatment o